Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.
C Gonzalez; D Hone; F R Noriega; C O Tacket; J R Davis; G Losonsky; J P Nataro; S Hoffman; A Malik; E Nardin; et al. (Profiled Authors: Myron M Levine; Marcelo B Sztein)
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore 21201.
The Journal of infectious diseases 1994;169(4):927-31.
rcsp, encoding amino acids 21-398 of Plasmodium falciparum circumsporozoite protein (CSP), under control of tacP was integrated into the chromosomal delta aroC locus of attenuated delta aroC, delta aroD Salmonella typhi CVD 908. By immunoblot and ELISA, rCSP expression was greater from a multicopy plasmid than from the single chromosomal gene. CVD 908 omega (delta aroC1019::tacP-rcsp) was well tolerated by 10 volunteers who were fed two doses of 5 x 10(7) organisms 8 days apart. Seven subjects excreted the vaccine strain for 1-3 days. All subjects developed serologic responses to O and H antigens of the live vector, whereas 3 vaccinees responded to the foreign antigen: 1 developed an 80-fold rise in serum anti-sporozoite antibody, another had a 4-fold rise in antibody to a recombinant portion of CSP (residues 309-345), while a third vaccinee developed CSP-specific CD8+ cytotoxic T lymphocyte activity. This is the first report of attenuated S. typhi eliciting a human serologic or a cytotoxic T lymphocyte response to a foreign protein. Improved foreign gene expression should enhance immunogenicity.
13 Originating Grant
-
1.
Levine, Myron Max
Recombinant & live oral Salmonella typhi hybrid vaccines
1 April 1990 - 28 February 2009
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
2.
LEVINE, MYRON M
-
3.
LEVINE, MYRON M
-
4.
LEVINE, MYRON M
-
5.
LEVINE, MYRON M
-
6.
LEVINE, MYRON M
-
7.
LEVINE, MYRON M
-
8.
LEVINE, MYRON M
-
9.
LEVINE, MYRON M
-
10.
LEVINE, MYRON M
-
11.
LEVINE, MYRON M
-
12.
LEVINE, MYRON M
-
13.
LEVINE, MYRON M
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
1992D A Herrington; G A Losonsky; G Smith; F Volvovitz; M Cochran; K Jackson; S L Hoffman; D M Gordon; M M Levine; R Edelman
Vaccine 1992;10(12):841-6. -
2.
1998C R González; F R Noriega; S Huerta; A Santiago; M Vega; J Paniagua; V Ortiz-Navarrete; A Isibasi; M M Levine
Vaccine 1998;16(9-10):1043-52. -
3.
2007Magaly Chinchilla; Marcela F Pasetti; Sandra Medina-Moreno; Jin Yuan Wang; Oscar G Gomez-Duarte; Rick Stout; Myron M Levine; James E Galen
Infection and immunity 2007;75(8):3769-79.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
628









-
166









-
73









-
66









-
44









-
118










